The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.
Synthesis and Biological Evaluation of Bupropion Analogues as Potential Pharmacotherapies for Cocaine Addiction
Abstract
A series of bupropion ( 1a ) analogues ( 1b−1ff ) were synthesized, and their in vitro and in vivo pharmacological properties evaluated with the goal of developing a 1a analogue that had better properties for treating addictions. Their in vitro pharmacological properties were examined by [ 3 H]dopamine ([ 3 H]DA), [ 3 H]serotonin ([ 3 H]5HT), and [ 3 H]norepinephrine ([ 3 H]NE) uptake inhibition studies, and by binding studies at the dopamine, serotonin, and norepinephrine transporters using [ 125 I]RTI-55 in cloned transporters. Several analogues showed increased [ 3 H]DA uptake inhibition with reduced or little change in [ 3 H]5HT and [ 3 H]NE uptake inhibition relative to bupropion. Thirty-five analogues were evaluated in a 1 h locomotor activity observation test and 32 in an 8 h locomotor activity observation test and compared to the locomotor activity of cocaine. Twenty-four analogues were evaluated for generalization to cocaine drug discrimination after i.p. administration, and twelve analogues were tested in a time course cocaine discrimination study using oral administration. 2-( N -Cyclopropylamino)-3-chloropropiophenone ( 1x ) had the most favorable in vitro efficacy and in vivo pharmacological profile for an indirect dopamine agonist pharmacotherapy for treating cocaine, methamphetamine, nicotine, and other drugs of abuse addiction.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gatley, S. J., Hitzemann, R., Chen, A. D., Dewey, S. L., & Pappas, N. (1997) · Nature · doi:10.1038/386830a0 · Cited by 854
Volkow, N. D. (1995) · Archives of General Psychiatry · doi:10.1001/archpsyc.1995.03950180042006 · Cited by 575
Bupropion for the treatment of methamphetamine dependence
Elkashef, A. M., Rawson, R. A., Anderson, A. L., Li, S.-H., Holmes, T., Smith, E. V., Chiang, N., Kahn, R., Vocci, F., Ling, W., et al. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301481 · Cited by 234
A multicenter trial of bupropion for cocaine dependence in methadone-maintained patients
Margolin, A., Kosten, T. R., Avants, S. K., Wilkins, J., Ling, W., Beckson, M., Arndt, I. O., Cornish, J., Ascher, J. A., Li, S.-H., et al. (1995) · Drug and Alcohol Dependence · doi:10.1016/0376-8716(95)01198-6 · Cited by 168
Li, S. X.-M., Perry, K. W., & Wong, D. T. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(01)00160-5 · Cited by 156
Cited by
Visible‐Light Photocatalysis: Does It Make a Difference in Organic Synthesis?
Marzo, L., Pagire, S. K., Reiser, O., & König, B. (2018) · Angewandte Chemie International Edition · doi:10.1002/anie.201709766 · Cited by 2,178
Photokatalyse mit sichtbarem Licht: Welche Bedeutung hat sie für die organische Synthese?
Marzo, L., Pagire, S. K., Reiser, O., & König, B. (2018) · Angewandte Chemie · doi:10.1002/ange.201709766 · Cited by 390
Cathinone derivatives: A review of their chemistry, pharmacology and toxicology
Kelly, J. P. (2011) · Drug Testing and Analysis · doi:10.1002/dta.313 · Cited by 346
Metadata
- Authors
- Carroll, F. I., Blough, B. E., Abraham, P., Mills, A. C., Holleman, J. A., Wolckenhauer, S. A., Decker, A. M., Landavazo, A., McElroy, K. T., Navarro, H. A., Gatch, M. B., & Forster, M. J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2009-10-12
- Volume
- 52
- Issue
- 21
- Pages
- 6768-6781
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W4243307001
- Cited by
- 159
- References
- 5
- FWCI
- 2.13
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.